RaiseFX Review 2026: FSCA-regulated forex CFD broker, leverage up to 1:500
RaiseFX is an FSCA regulated forex and CFD broker , based in Johannesburg, South Africa. It offers leverage up to 1:500, over 500 tradable instruments on MetaTrader 5, and competitive spreads. It is our top recommendation for traders looking for a regulated broker with professional trading conditions and high leverage.
What is RaiseFX?
RaiseFX is the forex and CFD broker of the Raise group, regulated by the FSCA (licence n°50506) (Financial Sector Conduct Authority) under licence. Based in Johannesburg, South Africa, RaiseFX targets active traders looking for a regulated broker with professional trading conditions.
The FSCA is South Africa's official financial regulatory authority. It is internationally recognized for its strict standards and allows the brokers it regulates to offer higher leverage than European regulators like CySEC or the FCA, which is a concrete advantage for experienced traders.
RaiseFX operates on MetaTrader 5 (MT5), the most advanced trading platform available on the market, offering technical analysis tools, algorithmic trading and fast order execution.
Trading conditions in detail
| Parameter | Details |
|---|---|
| Regulation | FSCA licence |
| Headquarters | Johannesburg, South Africa |
| Platform | MetaTrader 5 (MT5) |
| Maximum leverage | 1:500 |
| Available instruments | 500+ |
| Forex | Major, minor and exotic pairs |
| Indices | Global indices (S&P 500, DAX, CAC 40...) |
| Commodities | Gold, silver, oil, natural gas |
| Cryptocurrencies | Bitcoin, Ethereum and major cryptos |
| EA robots | Allowed (MT5) |
| Overnight trading | Allowed |
| Scalping | Allowed |
Available instruments
Pros and cons
- Official FSCA regulation, internationally recognized authority
- Leverage up to 1:500, among the highest in the regulated market
- Over 500 instruments on a single MT5 platform
- Algorithmic trading (EA robots) natively supported on MT5
- Scalping and overnight trading allowed without restrictions
- Among the lowest trading costs (tight spreads + zero commission), which helps optimize net trading performance
- Relatively new broker, limited track record
- Educational resources are still lighter than long-established brokers
- MT5 only, no MT4 or proprietary platform
Our scores by criteria
RaiseFX vs the competition
| Criteria | RaiseFX | Pepperstone | XM |
|---|---|---|---|
| Regulation | FSCA ✓ | ASIC, FCA, CySEC | CySEC, ASIC, IFSC |
| Max leverage | 1:500 | 1:500 | 1:888 |
| Instruments | 500+ | 1,200+ | 1,000+ |
| Platform | MT5 | MT4/MT5/cTrader | MT4/MT5 |
| EA robots | Allowed | Allowed | Allowed |
| Regulated group | Yes (Raise group) | Yes | Yes |
Who is RaiseFX for?
RaiseFX is particularly suited to two profiles.
The experienced trader seeking high leverage under official regulation. 1:500 leverage under an FSCA licence is rare in the regulated broker market. Most CySEC or FCA regulated brokers are limited to 1:30 for European retail clients. RaiseFX offers a regulated alternative with professional conditions.
The trader already using RaiseMyFunds who wants to trade with their own capital on the same regulatory infrastructure. The consistency of the Raise group (same FSCA licence for RaiseMyFunds and RaiseFX) is an advantage in terms of reliability and trust.
Final verdict
The best FSCA regulated broker for active traders in 2026
RaiseFX is our top recommendation for traders looking for a regulated broker with high leverage and a wide range of instruments on MT5. FSCA regulation, leverage up to 1:500 and access to over 500 instruments make it a strong offering for active traders. Its position within the Raise group, which also operates RaiseMyFunds, strengthens its institutional credibility.
Open a RaiseFX account →Sources & Methodology
This review is based on real testing by our analyst team, official website consultation, terms and conditions analysis, regulatory status verification with relevant authorities, and user reviews from Trustpilot and specialized forums. Our complete methodology is detailed on our methodology page. Last verified: May 2026.